1. Home
  2. PAGS vs TARS Comparison

PAGS vs TARS Comparison

Compare PAGS & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PAGS

PagSeguro Digital Ltd.

HOLD

Current Price

$8.76

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$62.92

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAGS
TARS
Founded
2006
2016
Country
Brazil
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.7B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
PAGS
TARS
Price
$8.76
$62.92
Analyst Decision
Buy
Buy
Analyst Count
5
6
Target Price
$12.00
$89.00
AVG Volume (30 Days)
2.9M
435.0K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
1.42%
N/A
EPS Growth
N/A
48.21
EPS
N/A
N/A
Revenue
N/A
$451,360,000.00
Revenue This Year
$11.07
$56.43
Revenue Next Year
$7.26
$30.19
P/E Ratio
$7.74
N/A
Revenue Growth
N/A
146.71
52 Week Low
$7.74
$38.51
52 Week High
$12.32
$85.25

Technical Indicators

Market Signals
Indicator
PAGS
TARS
Relative Strength Index (RSI) 43.12 54.83
Support Level $8.54 $61.24
Resistance Level $10.32 $66.36
Average True Range (ATR) 0.28 2.68
MACD 0.05 0.49
Stochastic Oscillator 32.04 83.35

Price Performance

Historical Comparison
PAGS
TARS

About PAGS PagSeguro Digital Ltd.

PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: